nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Thiotepa—urinary bladder cancer	0.0897	0.0897	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Epirubicin—urinary bladder cancer	0.0361	0.0361	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Doxorubicin—urinary bladder cancer	0.0334	0.0334	CcSEcCtD
Clavulanate—Thrombophlebitis—Mitomycin—urinary bladder cancer	0.03	0.03	CcSEcCtD
Clavulanate—Induration—Etoposide—urinary bladder cancer	0.0289	0.0289	CcSEcCtD
Clavulanate—Pain—Carboplatin—urinary bladder cancer	0.0147	0.0147	CcSEcCtD
Clavulanate—Leukopenia—Mitomycin—urinary bladder cancer	0.014	0.014	CcSEcCtD
Clavulanate—Pruritus—Valrubicin—urinary bladder cancer	0.0131	0.0131	CcSEcCtD
Clavulanate—Diarrhoea—Valrubicin—urinary bladder cancer	0.0127	0.0127	CcSEcCtD
Clavulanate—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Clavulanate—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Clavulanate—Swelling—Fluorouracil—urinary bladder cancer	0.0123	0.0123	CcSEcCtD
Clavulanate—Vomiting—Valrubicin—urinary bladder cancer	0.0118	0.0118	CcSEcCtD
Clavulanate—Rash—Valrubicin—urinary bladder cancer	0.0117	0.0117	CcSEcCtD
Clavulanate—Dermatitis—Valrubicin—urinary bladder cancer	0.0117	0.0117	CcSEcCtD
Clavulanate—Nausea—Valrubicin—urinary bladder cancer	0.011	0.011	CcSEcCtD
Clavulanate—Pain—Mitomycin—urinary bladder cancer	0.0109	0.0109	CcSEcCtD
Clavulanate—Swelling—Etoposide—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Clavulanate—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.01	0.01	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.0099	0.0099	CcSEcCtD
Clavulanate—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00933	0.00933	CcSEcCtD
Clavulanate—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00925	0.00925	CcSEcCtD
Clavulanate—Haemoglobin—Thiotepa—urinary bladder cancer	0.00909	0.00909	CcSEcCtD
Clavulanate—Haemorrhage—Thiotepa—urinary bladder cancer	0.00904	0.00904	CcSEcCtD
Clavulanate—Diarrhoea—Mitomycin—urinary bladder cancer	0.00874	0.00874	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.00846	0.00846	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.0084	0.0084	CcSEcCtD
Clavulanate—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00825	0.00825	CcSEcCtD
Clavulanate—Vomiting—Mitomycin—urinary bladder cancer	0.00812	0.00812	CcSEcCtD
Clavulanate—Rash—Mitomycin—urinary bladder cancer	0.00806	0.00806	CcSEcCtD
Clavulanate—Dermatitis—Mitomycin—urinary bladder cancer	0.00805	0.00805	CcSEcCtD
Clavulanate—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00765	0.00765	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00764	0.00764	CcSEcCtD
Clavulanate—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00761	0.00761	CcSEcCtD
Clavulanate—Nausea—Mitomycin—urinary bladder cancer	0.00759	0.00759	CcSEcCtD
Clavulanate—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00752	0.00752	CcSEcCtD
Clavulanate—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00748	0.00748	CcSEcCtD
Clavulanate—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00719	0.00719	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00717	0.00717	CcSEcCtD
Clavulanate—Leukopenia—Thiotepa—urinary bladder cancer	0.00705	0.00705	CcSEcCtD
Clavulanate—Convulsion—Thiotepa—urinary bladder cancer	0.00682	0.00682	CcSEcCtD
Clavulanate—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.0065	0.0065	CcSEcCtD
Clavulanate—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00629	0.00629	CcSEcCtD
Clavulanate—Erythema multiforme—Etoposide—urinary bladder cancer	0.00614	0.00614	CcSEcCtD
Clavulanate—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.00608	0.00608	CcSEcCtD
Clavulanate—Leukopenia—Gemcitabine—urinary bladder cancer	0.00593	0.00593	CcSEcCtD
Clavulanate—Leukopenia—Fluorouracil—urinary bladder cancer	0.00583	0.00583	CcSEcCtD
Clavulanate—Convulsion—Fluorouracil—urinary bladder cancer	0.00564	0.00564	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.00563	0.00563	CcSEcCtD
Clavulanate—Leukopenia—Cisplatin—urinary bladder cancer	0.00553	0.00553	CcSEcCtD
Clavulanate—Pain—Thiotepa—urinary bladder cancer	0.00549	0.00549	CcSEcCtD
Clavulanate—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.0054	0.0054	CcSEcCtD
Clavulanate—Convulsion—Cisplatin—urinary bladder cancer	0.00535	0.00535	CcSEcCtD
Clavulanate—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00531	0.00531	CcSEcCtD
Clavulanate—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00529	0.00529	CcSEcCtD
Clavulanate—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.0052	0.0052	CcSEcCtD
Clavulanate—Urticaria—Thiotepa—urinary bladder cancer	0.0051	0.0051	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00506	0.00506	CcSEcCtD
Clavulanate—Leukopenia—Etoposide—urinary bladder cancer	0.00506	0.00506	CcSEcCtD
Clavulanate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00504	0.00504	CcSEcCtD
Clavulanate—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00493	0.00493	CcSEcCtD
Clavulanate—Convulsion—Etoposide—urinary bladder cancer	0.0049	0.0049	CcSEcCtD
Clavulanate—Eosinophilia—Methotrexate—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00479	0.00479	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00474	0.00474	CcSEcCtD
Clavulanate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00473	0.00473	CcSEcCtD
Clavulanate—Pain—Gemcitabine—urinary bladder cancer	0.00462	0.00462	CcSEcCtD
Clavulanate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00462	0.00462	CcSEcCtD
Clavulanate—Pruritus—Thiotepa—urinary bladder cancer	0.00455	0.00455	CcSEcCtD
Clavulanate—Pain—Fluorouracil—urinary bladder cancer	0.00454	0.00454	CcSEcCtD
Clavulanate—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00452	0.00452	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—urinary bladder cancer	0.0045	0.0045	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00443	0.00443	CcSEcCtD
Clavulanate—Diarrhoea—Thiotepa—urinary bladder cancer	0.0044	0.0044	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00439	0.00439	CcSEcCtD
Clavulanate—Pain—Cisplatin—urinary bladder cancer	0.00431	0.00431	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Clavulanate—Urticaria—Fluorouracil—urinary bladder cancer	0.00422	0.00422	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00417	0.00417	CcSEcCtD
Clavulanate—Vomiting—Thiotepa—urinary bladder cancer	0.00408	0.00408	CcSEcCtD
Clavulanate—Rash—Thiotepa—urinary bladder cancer	0.00405	0.00405	CcSEcCtD
Clavulanate—Dermatitis—Thiotepa—urinary bladder cancer	0.00405	0.00405	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Clavulanate—Pain—Etoposide—urinary bladder cancer	0.00395	0.00395	CcSEcCtD
Clavulanate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Clavulanate—Haemoglobin—Methotrexate—urinary bladder cancer	0.00391	0.00391	CcSEcCtD
Clavulanate—Haemorrhage—Methotrexate—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Clavulanate—Hepatitis—Methotrexate—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Clavulanate—Pruritus—Gemcitabine—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Clavulanate—Nausea—Thiotepa—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Clavulanate—Pruritus—Fluorouracil—urinary bladder cancer	0.00376	0.00376	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Clavulanate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Clavulanate—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Clavulanate—Urticaria—Etoposide—urinary bladder cancer	0.00367	0.00367	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—urinary bladder cancer	0.00366	0.00366	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Clavulanate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Clavulanate—Diarrhoea—Cisplatin—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Clavulanate—Vomiting—Gemcitabine—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Clavulanate—Rash—Gemcitabine—urinary bladder cancer	0.00341	0.00341	CcSEcCtD
Clavulanate—Dermatitis—Gemcitabine—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Clavulanate—Hypersensitivity—Etoposide—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Clavulanate—Vomiting—Fluorouracil—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Clavulanate—Rash—Fluorouracil—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Clavulanate—Dermatitis—Fluorouracil—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Clavulanate—Pruritus—Etoposide—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Clavulanate—Nausea—Gemcitabine—urinary bladder cancer	0.00321	0.00321	CcSEcCtD
Clavulanate—Vomiting—Cisplatin—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Clavulanate—Rash—Cisplatin—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Clavulanate—Dermatitis—Cisplatin—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Clavulanate—Diarrhoea—Etoposide—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Clavulanate—Nausea—Fluorouracil—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Clavulanate—Leukopenia—Methotrexate—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Clavulanate—Nausea—Cisplatin—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Clavulanate—Convulsion—Methotrexate—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Clavulanate—Vomiting—Etoposide—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Clavulanate—Rash—Etoposide—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Clavulanate—Dermatitis—Etoposide—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Clavulanate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Clavulanate—Nausea—Etoposide—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Clavulanate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Clavulanate—Pain—Methotrexate—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Clavulanate—Pain—Epirubicin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Clavulanate—Urticaria—Methotrexate—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Pain—Doxorubicin—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Clavulanate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Clavulanate—Pruritus—Methotrexate—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Clavulanate—Diarrhoea—Methotrexate—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Clavulanate—Vomiting—Methotrexate—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Clavulanate—Rash—Methotrexate—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Clavulanate—Dermatitis—Methotrexate—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Nausea—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Rash—Epirubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Nausea—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Clavulanate—Rash—Doxorubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
